BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37284045)

  • 1. The Metastatic Risk of Renal Cell Carcinoma by Primary Tumor Size and Subtype.
    Monda SM; Lui HT; Pratsinis MA; Chandrasekar T; Evans CP; Dall'Era MA
    Eur Urol Open Sci; 2023 Jun; 52():137-144. PubMed ID: 37284045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synchronous Metastasis Rates in T1 Renal Cell Carcinoma: A Surveillance, Epidemiology, and End Results Database-based Study.
    Pecoraro A; Palumbo C; Knipper S; Mistretta FA; Rosiello G; Tian Z; St-Hilaire PA; Shariat SF; Saad F; Lavallée L; Briganti A; Kapoor A; Fiori C; Porpiglia F; Karakiewicz PI
    Eur Urol Focus; 2021 Jul; 7(4):818-826. PubMed ID: 32169361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Impact of Histological Subtype on the Incidence, Timing, and Patterns of Recurrence in Patients with Renal Cell Carcinoma After Surgery-Results from RECUR Consortium.
    Abu-Ghanem Y; Powles T; Capitanio U; Beisland C; Järvinen P; Stewart GD; Gudmundsson EO; Lam TB; Marconi L; Fernandéz-Pello S; Nisen H; Meijer RP; Volpe A; Ljungberg B; Klatte T; Dabestani S; Bex A
    Eur Urol Oncol; 2021 Jun; 4(3):473-482. PubMed ID: 33109495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of histologic subtype and sarcomatoid transformation on metastasis in renal cell carcinoma: a single institute experience in 149 patients.
    Tirumani SH; Souza D; Krajewski KM; Jagannathan JP; Ramaiya NH; Shinagare AB
    Abdom Radiol (NY); 2016 Feb; 41(2):295-302. PubMed ID: 26867911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of metastatic renal cell carcinoma with correlation to subtype and primary tumor.
    Mai KT; Landry DC; Robertson SJ; Commons AS; Burns BF; Thijssen A; Collins J
    Pathol Res Pract; 2001; 197(10):671-5. PubMed ID: 11700888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous Cryoablation of Solitary, Sporadic Renal Cell Carcinoma: Outcome Analysis Based on Clear-Cell versus Papillary Subtypes.
    Haddad MM; Schmit GD; Kurup AN; Schmitz JJ; Boorjian SA; Geske J; Thompson RH; Callstrom MR; Atwell TD
    J Vasc Interv Radiol; 2018 Aug; 29(8):1122-1126. PubMed ID: 29887184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic and Lipidomic Reprogramming in Renal Cell Carcinoma Subtypes Reflects Regions of Tumor Origin.
    Schaeffeler E; Büttner F; Reustle A; Klumpp V; Winter S; Rausch S; Fisel P; Hennenlotter J; Kruck S; Stenzl A; Wahrheit J; Sonntag D; Scharpf M; Fend F; Agaimy A; Hartmann A; Bedke J; Schwab M
    Eur Urol Focus; 2019 Jul; 5(4):608-618. PubMed ID: 29452772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metastatic potential of renal tumors: Influence of histologic subtypes on definition of small renal masses, risk stratification, and future active surveillance protocols.
    Daugherty M; Sedaghatpour D; Shapiro O; Vourganti S; Kutikov A; Bratslavsky G
    Urol Oncol; 2017 Apr; 35(4):153.e15-153.e20. PubMed ID: 28202224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Probability of Aggressive Versus Indolent Histology Based on Renal Tumor Size: Implications for Surveillance and Treatment.
    Bhindi B; Thompson RH; Lohse CM; Mason RJ; Frank I; Costello BA; Potretzke AM; Hartman RP; Potretzke TA; Boorjian SA; Cheville JC; Leibovich BC
    Eur Urol; 2018 Oct; 74(4):489-497. PubMed ID: 30017400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of papillary and chromophobe cell type on disease-free survival after nephrectomy for renal cell carcinoma.
    Beck SD; Patel MI; Snyder ME; Kattan MW; Motzer RJ; Reuter VE; Russo P
    Ann Surg Oncol; 2004 Jan; 11(1):71-7. PubMed ID: 14699037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological and survival analysis of clinically advanced papillary and chromophobe renal cell carcinoma.
    Kaldany A; Paulucci DJ; Kannappan M; Beksac AT; Anastos H; Okhawere K; Sfakianos JP; Badani KK
    Urol Oncol; 2019 Oct; 37(10):727-734. PubMed ID: 31174958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of subtypes of metastatic renal-cell carcinoma: correlating findings of fine-needle aspiration biopsy and surgical pathology.
    Mai KT; Alhalouly T; Lamba M; Yazdi HM; Stinson WA
    Diagn Cytopathol; 2003 Feb; 28(2):66-70. PubMed ID: 12561022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histologic subtype needs to be considered after partial nephrectomy in patients with pathologic T1a renal cell carcinoma: papillary vs. clear cell renal cell carcinoma.
    Yoo S; You D; Jeong IG; Song C; Hong B; Hong JH; Ahn H; Kim CS
    J Cancer Res Clin Oncol; 2017 Sep; 143(9):1845-1851. PubMed ID: 28451753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel molecular signature identifies mixed subtypes in renal cell carcinoma with poor prognosis and independent response to immunotherapy.
    Büttner FA; Winter S; Stühler V; Rausch S; Hennenlotter J; Füssel S; Zastrow S; Meinhardt M; Toma M; Jerónimo C; Henrique R; Miranda-Gonçalves V; Kröger N; Ribback S; Hartmann A; Agaimy A; Stöhr C; Polifka I; Fend F; Scharpf M; Comperat E; Wasinger G; Moch H; Stenzl A; Gerlinger M; Bedke J; Schwab M; Schaeffeler E
    Genome Med; 2022 Sep; 14(1):105. PubMed ID: 36109798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient Characteristics and Survival Outcomes of Non-Metastatic, Non-Clear Cell Renal Cell Carcinoma.
    An J; Packiam VT; Chennamadhavuni A; Richards J; Jain J; Mott SL; Garje R
    Front Oncol; 2021; 11():786307. PubMed ID: 35083144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of type I and II papillary renal cell carcinoma (RCC) and clear cell RCC.
    Waldert M; Haitel A; Marberger M; Katzenbeisser D; Ozsoy M; Stadler E; Remzi M
    BJU Int; 2008 Nov; 102(10):1381-4. PubMed ID: 18782311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical behavior of chromophobe renal cell carcinoma is less aggressive than that of clear cell renal cell carcinoma, independent of Fuhrman grade or tumor size.
    Steffens S; Roos FC; Janssen M; Becker F; Steinestel J; Abbas M; Steinestel K; Wegener G; Siemer S; Thüroff JW; Hofmann R; Stöckle M; Schrader M; Hartmann A; Junker K; Kuczyk MA; Schrader AJ;
    Virchows Arch; 2014 Oct; 465(4):439-44. PubMed ID: 25178561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Metastasis Pattern of Renal Cell Carcinoma Is Influenced by Histologic Subtype, Grade, and Sarcomatoid Differentiation.
    Park HK
    Medicina (Kaunas); 2023 Oct; 59(10):. PubMed ID: 37893563
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of stage and grade migration on cancer specific mortality in renal cell carcinoma patients, according to clear cell vs. non-clear cell histology: A contemporary population-based analysis.
    Luzzago S; Palumbo C; Rosiello G; Knipper S; Pecoraro A; Mistretta FA; Tian Z; Musi G; Montanari E; Shariat SF; Saad F; Briganti A; de Cobelli O; Karakiewicz PI
    Urol Oncol; 2020 May; 38(5):506-514. PubMed ID: 32139292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.